This session will assess how healthcare and frontline medicine will emerge from the COVID-19 pandemic. Being one of the sectors that was most affected by the crisis, healthcare will be tackled from different points of view.
The session is composed of three conversations:

CONVERSATION 1 | Post-pandemic changes to healthcare and social welfare systems
16:00 – 18:00 CET

Speakers will discuss how social welfare and healthcare systems will be altered in the Post-COVID Era, as both a consequence and a response to the pandemic.


Agnès Soucat, Director for Health Systems Governance and Financing, World Health Organization

Beatrice Nere, Head of Southern Europe, G7 & G20, Global Policy & Advocacy, Bill & Melinda Gates Foundation

Leslie Curry, Professor of Public Health and Professor of Management, Yale School of Public Health

Penny Dash, Senior Partner, McKinsey & Company

Vikram Patel, Pershing Square Professor of Global Health and Wellcome Trust Principal Research Fellow, Harvard Medical School

CONVERSATION 2 | Risk assessment and prevention
16:00 – 18:00 CET

Medical risk assessment will be examined, particularly with a focus on how the spread of infectious diseases can be predicted and halted. Can we conceive and design a physical environment that is better suited to disease prevention?


Andrew J. Tatem, Director of WorldPop, University of Southampton

Christopher Dye, Professor of Epidemiology, University of Oxford

James E. Clyburn, Majority Whip, United States House of Representatives

Jeffrey Shaman, Professor, Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University

John P.A. Ioannidis, C.F. Rehnborg Chair in Disease Prevention, Stanford University

Robert C. Gallo, The Homer & Martha Gudelsky Distinguished Professor in Medicine, University of Maryland School of Medicine; Co-Founder & Director, Institute of Human Virology

Tolullah Oni, Clinical Senior Research Associate, MRC Epidemiology Unit; Honorary Associate Professor, University of Cambridge

Wolfgang Philipp, Head of Unit, Public Health, Country Knowledge, Crisis Management Directorate of the European Commission

CONVERSATION 3 | Technological breakthroughs driving medical advances
16:00 – 18:00 CET

This conversation will navigate the technological breakthroughs that are driving medical advances, with participants discussing their vision for the future of healthcare and medicine.


Edward Abrahams, President, Personalized Medicine Coalition

Jennifer Miller, Founder, Bioethics International

Kenji Shibuya, Professor and Director of the Institute of Population Health, King’s College London

Laurie H. Glimcher, President and CEO, Dana-Farber Cancer Institute; Richard and Susan Smith Professor of Medicine, Harvard Medical School

Luciana Borio, Vice President, In-Q-Tel

Nancy Brown, CEO, American Heart Association

Othman Laraki, Co-founder and CEO, Color

Peer M. Schatz, Managing Director, PS-Capital Management GmbH

Yann Le Cam, CEO, EURORDIS – Rare Diseased Europe

Yoshiyuki Sankai, CEO and President, CYBERDYNE Inc.